Sebetralstat Becomes First and Only FDA-Approved Oral, On-Demand Treatment for HAE
Sebetralstat becomes the first FDA-approved oral treatment for hereditary angioedema (HAE), offering rapid relief for patients experiencing acute attacks.
https://prabadinews.com/